hematopoietic-stem-cell-transplantation

Documents about hematopoietic-stem-cell-transplantation

• Safety and Exploratory Efficacy of HSC835 in Patients With Inherited Metabolic Disorders (IMD)#895785ClinicalTrials.gov
• Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment for Triple Negative Breast Cancer Patients#903392ClinicalTrials.gov
• Immediate Allogeneic Hematopoietic Stem Cell Transplantation Versus Re-treatment for Patients With High-Risk Acute Myeloid Leukemia#1009001ClinicalTrials.gov
• TKI Therapy Based on Molecular Monitoring in Allogeneic-HSCT Recipients With Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia#1046975ClinicalTrials.gov
• Trial Studying Maintenance Treatment With Lenalidomide and Dexamethasone Versus Lenalidomide, Dexamethasone and MLN9708 After Autologous Hematopoietic Stem Cell Transplantation in Patients With Newly-diagnosed Symptomatic Multiple Myeloma#826295ClinicalTrials.gov
• Treating Cancer-Related Fatigue Through Systematic Light Exposure#877619ClinicalTrials.gov
• Study to Evaluate the Safety and Pharmacokinetics of Efmarodocokin Alfa in Combination With Standard of Care in Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation#890990ClinicalTrials.gov
• Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of Bleeding in Patients Following Hematopoietic Stem Cell Transplantation#995066ClinicalTrials.gov
• Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor#1007574ClinicalTrials.gov
• Expanded Use of G-CSF Mobilized Donor CD34+ Selected Cells for Allogeneic Transplantation#829470ClinicalTrials.gov
• Orelabrutinib Combined With Standard Immunochemotherapy With or Without Autologous Hematopoietic Stem Cell Transplantation (Auto-HSCT) for Newly Diagnosed Diffuse Large B-cell Lymphoma (DLBCL)#813306ClinicalTrials.gov
• Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease#401988DataCite
• RUNX1-IT1 and AK026392.1 long non-coding RNAs as early predictors of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in acute leukemia.#621031NCBI PubMed Central
• Busulfan Concentration in Saliva and Plasma, and Its Relationship With Salivary Changes and Mucositis in the Digestive Tract of Patients Submitted to Hematopoietic Stem Cell Transplantation#833531ClinicalTrials.gov
• Expanded Access of Ruxolitinib Cream to Treat a Single Patient With cGVHD#1046926ClinicalTrials.gov
• Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation#825637ClinicalTrials.gov
• <b>Curriculum Vitae – Professor Salah Eddine Belakehal, MD | Senior Hematologist, Hospital Executive and Clinical Research Leader</b>#220412Figshare
• Fertility preservation in 2026: current landscape in Europe and the United States for children and adolescents undergoing hematopoietic stem cell transplantation—recommendations on behalf of the Westhafen Intercontinental Group#229803HAL (France)
• Immersive Virtual Reality Applied to Therapeutic Physical Exercise in Cellular Therapy#835788ClinicalTrials.gov
• Clinical Implications of HMGB1 in Patients Treated With Chemotherapy or Hematopoietic Stem Cell Transplantation#840452ClinicalTrials.gov
• Low Dose Decitabine + Modified BUCY Conditioning Regimen for High Risk Acute Myeloid Leukemia Undergoing Allo-HSCT#873698ClinicalTrials.gov
• Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation#882214ClinicalTrials.gov
• Methadone as an Alternative Treatment for Children Underdoing HSCT#911559ClinicalTrials.gov
• Effectiveness and Safety of InO±DLI for Relapsed B-ALL/LBL After Allo-HSCT#897005ClinicalTrials.gov
• Study of Pulmonary Complications in Pediatric Patients With Storage Disorders Undergoing Allogeneic Hematopoietic Stem Cell Transplantation#837423ClinicalTrials.gov
• Gemcitabine Hydrochloride, Clofarabine, and Busulfan Before Donor Stem Cell Transplant in Treating Patients With Refractory B-Cell or T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma#916057ClinicalTrials.gov
• Anti-CD19 CAR T Infusion Combined With Allogeneic Stem Cell Transplantation for B-cell Leukemia/Lymphoma#993628ClinicalTrials.gov
• CD19-BCMA Dual Nanobody Based CAR-T Cells for Patients With DSA#873668ClinicalTrials.gov
• High donor hemoglobin interacts with pre-transplant recipient neutropenia to modulate mortality after allogeneic hematopoietic stem cell transplantation: An exploratory, single-center, retrospective, real-world study#219397PLOS
• Efficacy and Safety of Sequential Autologous Hematopoietic Stem Cell Transplantation Combined With Tafasitamab, Lenalidomide, and Standard Immunochemotherapy for Relapsed/Refractory Diffuse Large B-cell Lymphoma#842521ClinicalTrials.gov
• Treatment of CD19 Chimeric Antigen Receptor T Cells for Pediatric Patients With CD19-positive B-cell Acute Lymphoblastic Leukemia Who Are Indicated for Hematopoietic Stem Cell Transplantation#801495ClinicalTrials.gov
• Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine#261491ClinicalTrials.gov
• A 3-cohort Randomized Study Evaluating the Role of New Immunotherapeutic Agents and of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Frontline Therapy of Adults With Acute Lymphoblastic Leukemia#435738ClinicalTrials.gov
• Rationale and Methods of a Surveillance System for Hematopoietic Stem Cell Transplantation in Patients With Hematological Malignancies: A Qualitative Participatory Action Research Approach in Middle-Income Countries-The Experience in Iran.#433871NCBI PubMed Central
• Association of social restrictions with fear of cancer recurrence in hematopoietic stem cell transplantation patients: an exploratory analysis of the potential chain mediation role of illness perception and cognitive emotion regulation.#659904NCBI PubMed Central
• Impact of defibrotide on survival in sinusoidal obstruction syndrome / veno-occlusive disease: a retrospective cohort study comparing two sequential treatment eras.#686622PubMed
• 10-day Decitabine, Fludarabine and 2 Gray TBI as Conditioning Strategy for Poor and Very Poor Risk AML in CR1#914456ClinicalTrials.gov
• Zoledronic Acid in Combination With Interleukin-2 to Expand Vγ9Vδ2 T Cells After T-replete Haplo-identical Allotransplant#869705ClinicalTrials.gov
• Serial Analysis of Chimerism in Patients With Refractory Cytopenia (RC) Transplanted With Reduced Intensity Conditioning (RIC)#833190ClinicalTrials.gov
• A Trial of Plerixafor/G-CSF as Additional Agents for Conditioning Before TCR Alpha/Beta Depleted HSCT in WAS Patients#1031100ClinicalTrials.gov
• Infusion of Allogeneic CD19-Specific T Cells From Peripheral Blood#889881ClinicalTrials.gov
• Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995#828073ClinicalTrials.gov
• A Novel Conditioning Regimen for Myelodysplastic Syndrome With Moderate High IPSS-M Score#842665ClinicalTrials.gov
• Blastic Plasmacytoid Dendritic Cell Neoplasm: A Single-Center Experience. Clinical Characterization, Mutational Landscape, and Clinical Outcome of Patients Undergoing Hematopoietic Stem Cell Transplantation Intensive Therapy#651442Dipòsit Digital de la Universitat de Barcelona
• Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders#842042ClinicalTrials.gov
• A Single-Arm, Prospective Study of TBI+BUMEL as Conditioning for SCT2 in Patients With Malignant Hematologic Diseases#835808ClinicalTrials.gov
• Atorvastatin for the Prophylaxis of Acute GVHD in Patients Undergoing Matched Sibling Allogeneic Transplantation#878789ClinicalTrials.gov
• Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hematopoietic Stem Cell Transplantation#840288ClinicalTrials.gov
• Extracorporeal Photopheresis Using Theraflex ECP™ for Patients With Refractory Chronic Graft Versus Host Disease (cGVHD)#840690ClinicalTrials.gov
• Characteristics and Dynamics of TCR Repertoire in Patients With Hematological Malignancies After Allo-HSCT#862229ClinicalTrials.gov